US Stock MarketDetailed Quotes

NVS Novartis AG

Watchlist
  • 107.220
  • -4.580-4.10%
Close Jul 18 16:00 ET
  • 107.500
  • +0.280+0.26%
Post 19:07 ET
217.08BMarket Cap13.75P/E (TTM)

Novartis AG Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Novartis AG Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Jul 18, 2024

Revenue(YoY)

12.87B

+9.60%
EPS(YoY)

1.59

+43.24%
Analyst Rating

Buy

Jul 2, 2024

Novartis AG Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Jan 31, 20252024/Q4-- / 12.508B--
Oct 29, 20242024/Q3-- / 12.499B--
Jul 18, 20242024/Q212.512B / 12.319B--
Apr 23, 20242024/Q111.829B / 11.498B--
Jan 31, 20242023/Q411.423B / 11.773B--
DatePeriodRevenue/EstimateEarnings Call
Jan 31, 20252024/Q4-- / 12.508B--
Oct 29, 20242024/Q3-- / 12.499B--
Jul 18, 20242024/Q212.512B / 12.319B--
Apr 23, 20242024/Q111.829B / 11.498B--
Jan 31, 20242023/Q411.423B / 11.773B--

Unlock Free Earnings Estimates

Novartis AG Earnings Reports

  • 6-K: Novartis Second Quarter and Half Year 2024 Condensed Interim Financial Report – Supplementary Data

    Jul 18 06:11 ET

  • 6-K: Financial Report Q1 2024

    Apr 23 06:09 ET

  • Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)

    Jan 31 07:46 ET

  • Novartis AG | 20-F: Registration statement / Annual report / Transition report

    Jan 31 07:41 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 2, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept CAR-T Therapy
    CAR-T Therapy
    Intraday-1.51%
    Cancer Research
    Cancer Research
    Intraday-1.84%